MedTrace Logo

9000 URETHRA STUDY: a Study About Urethroplasty for Urethral Stricture Disease

NCT04071925 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-01-03

No results posted yet for this study

Summary

It has been demonstrated that urethroplasty should be considered the gold standard treatment for urethral stricture disease as it yields higher long-term success rates than endoscopic treatment options such as direct vision internal urethrotomy (DVIU) or dilation. Many data about these procedures exist, although most of the publications about urethroplasty are retrospective and involve a tremendous risk of bias. To address these issues, this study is designed to prospectively gain evidence about this matter in all patient subgroups facing a potential treatment with urethroplasty: native men, native women, transmen, transwomen and children.

Conditions

  • Urethral Stricture

Interventions

PROCEDURE

Urethroplasty

Open reconstructive surgery to restore urethral patency in case of urethral stricture disease.

Sponsors & Collaborators

  • University Hospital, Ghent

    lead OTHER

Principal Investigators

  • Nicolaas Lumen · University Hospital, Ghent

  • Marjan Waterloos · University Hospital, Ghent

  • Wesley Verla · University Hospital, Ghent

Eligibility

Min Age
6 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2029-12-31
Completion
2029-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04071925 on ClinicalTrials.gov